Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
Saved in:
| Title: | Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity. |
|---|---|
| Authors: | Gorman DM; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Li XX; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Lee JD; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Fung JN; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Cui CS; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Lee HS; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Rolfe BE; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia., Woodruff TM; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.; Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia., Clark RJ; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia. |
| Source: | Journal of medicinal chemistry [J Med Chem] 2021 Nov 25; Vol. 64 (22), pp. 16598-16608. Date of Electronic Publication: 2021 Nov 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
